Sinopharm Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
71
- Portfolio
-
50
- Exits
-
8
Sinopharm Capital General Information
Description
Sinopharm Capital is a venture capital arm of Sinopharm Group focusing on medical and health fields. The firm is primarily based in Shanghai, China and prefers to invest in the healthcare, life science and biotechnology sectors.
Contact Information
Website
www.sinopharmcapital.com
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Number 266, Hankou Road
- 16th Floor
- Shanghai, Huangpu 200010
- China
Sinopharm Capital Investments (71)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| AstraBio (China) | 29-Jun-2022 | Early Stage VC | 000.00 | Biotechnology | Startup | |
| 00000000 000000000 | 31-Mar-2022 | 00000 00000 | 000.00 | Drug Discovery | Startup | 000 0000 |
| 000000000 0000000 | 31-Mar-2022 | 0000 00000 | 00.000 | Enterprise Systems (Healthcare) | Startup | 00000 00 |
| 000000000 | 03-Mar-2022 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| 0000000000 | 14-Feb-2022 | 00000 00000 | 000.00 | Biotechnology | Pre-Clinical Trials | |
| 00000000 (0000000 | 24-Nov-2021 | 00000 00000 | Laboratory Services (Healthcare) | Clinical Trials - General | ||
| 00000 000000000000 | 15-Nov-2021 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | |
| 000000000 | 02-Nov-2021 | 00000 00000 | 000.00 | Diagnostic Equipment | Generating Revenue | |
| Neowise Biotechnology | 14-Oct-2021 | Early Stage VC | Drug Discovery | Startup | ||
| Xiyuan Anjian Pharmaceutical | 01-Oct-2021 | Seed Round | 000.00 | Drug Discovery | Startup |
Sinopharm Capital Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Abbisko Therapeutics | 13-Oct-2021 | IPO | 00000 |
| 00000 | 18-Jun-2021 | 000 | 00000 |
| 0000 | 06-May-2021 | 000 | 000.00 |
| 000000 000000 0000 | 04-Dec-2020 | 000 00 00000000 | |
| 000000000 | 29-Jul-2020 | 000 | 00000 |
| 00000 000000000000 | 10-Oct-2019 | 000000000000000000 | 00000 |
| Guangzhou Ambition (LBP) Pharmaceutical Technology | 23-Dec-2016 | Merger/Acquisition | 00000 |
| Oramed Pharmaceuticals | Secondary Transaction - Open Market |
Sinopharm Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Sinopharm Capital Team (3)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Aimin Wu | Founder, Managing Partner & President | 0 | 0 | Shanghai, China | |
| Han Zhao | Executive | 0 | Shanghai, China | ||
| Xiaoming Yang | Executive | Shanghai, China |
Sinopharm Capital Co-Investors (114)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| CICC Capital | 4 |
|
|
||
| China Growth Capital | 0 | 0 |
|
|
|
| Lilly Asia Ventures | 0 | 0 | 0 |
|
|
| Qiming Venture Partners | 0 | 0 |
|
|
|
| TF Capital | 0 |
|
|